NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/22/2025
Back to search
Official data from USPTO
LUGENE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
07/22/2025
Trademark type
Combined
Nice classes
44
Filing date
04/29/2021
Registration date
07/22/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/22/2025
Last transaction
07/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/19/2023
First use in commerce
12/19/2023
Drawing code
5
Owner type
16
Owner location
Charlottesville, VA, US
Examiner
RENNEKER, CHRISTOPHER JOHN
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word LuGENE with capital letters L, G, E, N, and E. The u is lowercase.
Holders and representatives
Holders
Ampel, LLC
Representatives
Patrick C. Asplin FLORA PETTIT
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical information servicesproviding reports and information relating to disease activity in individuals suffering from autoimmune diseasescardiovascular diseaseinflammatory diseasesneurological diseasesinfectious diseases and oncological diseases based on their genetic profiles and gene expression; Providing reports and information relating to the best drug therapies and treatment options for individuals with autoimmune diseasescardiovascular diseaseinflammatory diseasesneurological diseasesinfectious diseases and oncological diseases based on their genetic profile and gene expression
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/22/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/16/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/03/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/02/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/01/2025
IUAF
USE AMENDMENT FILED
03/28/2025
EISU
TEAS STATEMENT OF USE RECEIVED
03/28/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/23/2024
EX5G
SOU EXTENSION 5 GRANTED
09/23/2024
EXT5
SOU EXTENSION 5 FILED
09/23/2024
EEXT
SOU TEAS EXTENSION RECEIVED
09/23/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/29/2024
EX4G
SOU EXTENSION 4 GRANTED
03/28/2024
EXT4
SOU EXTENSION 4 FILED
03/28/2024
EEXT
SOU TEAS EXTENSION RECEIVED
03/28/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/29/2023
EX3G
SOU EXTENSION 3 GRANTED
09/27/2023
EXT3
SOU EXTENSION 3 FILED
09/27/2023
EEXT
SOU TEAS EXTENSION RECEIVED
09/27/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/30/2023
EX2G
SOU EXTENSION 2 GRANTED
03/28/2023
EXT2
SOU EXTENSION 2 FILED
03/28/2023
EEXT
SOU TEAS EXTENSION RECEIVED
03/28/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/27/2022
EX1G
SOU EXTENSION 1 GRANTED
09/23/2022
EXT1
SOU EXTENSION 1 FILED
09/23/2022
EEXT
SOU TEAS EXTENSION RECEIVED
09/23/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/29/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/01/2022
PUBO
PUBLISHED FOR OPPOSITION
02/01/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/29/2021
DOCK
ASSIGNED TO EXAMINER
12/29/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/03/2021
NWAP
NEW APPLICATION ENTERED
05/03/2021
Continuous trademark protection
Get notified about every new filing that threatens LUGENE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.